Search

Search Constraints

You searched for: Author/Creator Chian, Chih-Feng

Search Results

5. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial. Issue 11 (November 2020)